Anders Magnusson

Title: Innovations by Anders Magnusson

Introduction

Anders Magnusson is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of modified release formulations. With a total of 2 patents, his work focuses on improving the efficacy of pharmaceutical compositions.

Latest Patents

Anders Magnusson's latest patents include a modified release pharmaceutical formulation. This composition comprises an active ingredient that is a compound of a specific formula, which includes various substituents and is designed for the treatment of cardiovascular disorders. The formulation may only contain iota-carrageenan and a neutral gelling polymer when the compound is in the form of a salt. This innovative approach aims to enhance the therapeutic effects of the medication.

Career Highlights

Anders is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise in modified release formulations has positioned him as a valuable asset to his team.

Collaborations

Anders collaborates with Mikael Thune, a fellow professional in the field. Their partnership exemplifies the importance of teamwork in driving innovation and advancing pharmaceutical research.

Conclusion

Anders Magnusson's contributions to the field of pharmaceuticals through his innovative patents and work at AstraZeneca highlight his commitment to improving healthcare solutions. His research continues to pave the way for advancements in the treatment of cardiovascular disorders.